Logo image of CRKN

CROWN ELECTROKINETICS CORP (CRKN) Stock Fundamental Analysis

NASDAQ:CRKN - Nasdaq - US2283394045 - Common Stock - Currency: USD

4.55  -0.05 (-1.09%)

After market: 4.54 -0.01 (-0.22%)

Fundamental Rating

2

CRKN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. CRKN has a bad profitability rating. Also its financial health evaluation is rather negative. CRKN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CRKN had negative earnings in the past year.
CRKN had a negative operating cash flow in the past year.
CRKN had negative earnings in each of the past 5 years.
CRKN had a negative operating cash flow in each of the past 5 years.
CRKN Yearly Net Income VS EBIT VS OCF VS FCFCRKN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

CRKN's Return On Assets of -202.17% is on the low side compared to the rest of the industry. CRKN is outperformed by 97.59% of its industry peers.
Looking at the Return On Equity, with a value of -359.07%, CRKN is doing worse than 93.98% of the companies in the same industry.
Industry RankSector Rank
ROA -202.17%
ROE -359.07%
ROIC N/A
ROA(3y)-253.99%
ROA(5y)-773.83%
ROE(3y)-1197.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRKN Yearly ROA, ROE, ROICCRKN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 1K -1K 2K -2K

1.3 Margins

CRKN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRKN Yearly Profit, Operating, Gross MarginsCRKN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 -5K -10K -15K

More info and screens

3

2. Health

2.1 Basic Checks

CRKN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRKN has been increased compared to 1 year ago.
The number of shares outstanding for CRKN has been increased compared to 5 years ago.
Compared to 1 year ago, CRKN has an improved debt to assets ratio.
CRKN Yearly Shares OutstandingCRKN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CRKN Yearly Total Debt VS Total AssetsCRKN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -13.49, we must say that CRKN is in the distress zone and has some risk of bankruptcy.
CRKN has a worse Altman-Z score (-13.49) than 86.75% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that CRKN is not too dependend on debt financing.
CRKN has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. CRKN outperforms 91.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -13.49
ROIC/WACCN/A
WACC8.48%
CRKN Yearly LT Debt VS Equity VS FCFCRKN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

CRKN has a Current Ratio of 1.40. This is a normal value and indicates that CRKN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.40, CRKN is doing worse than 72.29% of the companies in the same industry.
CRKN has a Quick Ratio of 1.40. This is a normal value and indicates that CRKN is financially healthy and should not expect problems in meeting its short term obligations.
CRKN has a Quick ratio of 1.40. This is comparable to the rest of the industry: CRKN outperforms 54.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
CRKN Yearly Current Assets VS Current LiabilitesCRKN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.14% over the past year.
Looking at the last year, CRKN shows a very strong growth in Revenue. The Revenue has grown by 23871.19%.
CRKN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.23% yearly.
EPS 1Y (TTM)55.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.81%
Revenue 1Y (TTM)23871.19%
Revenue growth 3Y15.23%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRKN Yearly Revenue VS EstimatesCRKN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K 500K
CRKN Yearly EPS VS EstimatesCRKN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 -500K -1M -1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRKN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRKN Price Earnings VS Forward Price EarningsCRKN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRKN Per share dataCRKN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CRKN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWN ELECTROKINETICS CORP

NASDAQ:CRKN (2/21/2025, 8:10:55 PM)

After market: 4.54 -0.01 (-0.22%)

4.55

-0.05 (-1.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)03-31 2025-03-31
Inst Owners0.78%
Inst Owner Change4269.83%
Ins Owners0.01%
Ins Owner Change0%
Market Cap7.92M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)-6.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-11.11
FCFYN/A
OCF(TTM)-9.26
OCFYN/A
SpS8.13
BVpS5.7
TBVpS5.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -202.17%
ROE -359.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-253.99%
ROA(5y)-773.83%
ROE(3y)-1197.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 362.94%
Cap/Sales 22.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z -13.49
F-Score4
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)682.43%
Cap/Depr(5y)455.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23871.19%
Revenue growth 3Y15.23%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-58.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.96%
OCF growth 3YN/A
OCF growth 5YN/A